HIV, hepatitis C and HIV/hepatitis C virus co-infection in vulnerable populations
Authors:
- Derek BoothroydDBDerek Boothroyd
- Lawrence R DeytonLDLawrence R Deyton
- 1 October 2005
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 19 (Suppl 3) , S13-S19
Abstract
To describe basic patient demographic and clinical characteristics of HIV-infected and HIV/hepatitis C virus (HCV)-co-infected patients receiving care in the Department of Veterans Affairs (VA) with a focus on some patient factors that place such patients at an increased risk of poor health outcomes. An observational retrospective cohort study. The study cohort consisted of veterans in the VA Immunology Case Registry who received care in the VA in 2002. Of 18 349 HIV-infected patients, 6782 (37.0%) were HCV seropositive. Compared with HIV-alone-infected patients, HIV/HCV-co-infected patients were older, more likely to be men, more likely to be black or Hispanic, and more likely to report intravenous drug use as a risk factor for HIV acquisition. HIV/HCV-co-infected patients were more likely to have diagnoses of mental health illness, depression, alcohol abuse, substance abuse and hard drug abuse compared with HIV-alone-infected patients. Co-infected patients were less likely to have a history of an AIDS opportunistic infection ever and were less likely to have received HIV antiretroviral drugs in 2002. The VA's HIV and HIV/HCV-co-infected patient populations have very high rates of additional comorbid conditions that complicate both the pharmacological therapy and clinical course of both HIV and HCV infections. Given the overlap in viral illness and comorbidities, optimal models of integrated care need to be developed for populations with HIV, HCV, and HIV/HCV co-infection and who need substance abuse treatment or mental healthcare.Keywords
This publication has 29 references indexed in Scilit:
- Hepatitis C in the HIV-Infected PersonAnnals of Internal Medicine, 2003
- Hepatitis C Virus Prevalence among Patients Infected with Human Immunodeficiency Virus: A Cross-Sectional Analysis of the US Adult AIDS Clinical Trials GroupClinical Infectious Diseases, 2002
- The immunology case registryJournal of Clinical Epidemiology, 2001
- Paroxetine for the Prevention of Depression Induced by High-Dose Interferon AlfaNew England Journal of Medicine, 2001
- Natural history of HIV infection in the_era of combination antiretroviral therapyAIDS, 1999
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994New England Journal of Medicine, 1999
- Prediction of the Depressive Effects of Interferon Alfa Therapy by the Patient's Initial Affective StateNew England Journal of Medicine, 1999
- A Systematic Review of the Mortality of DepressionPsychosomatic Medicine, 1999
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Mortality and medical comorbidity among psychiatric patients: a reviewPsychiatric Services, 1996